1. Food and Drug Administration (FDA) . Coronavirus treatment acceleration program (CTAP). Available: https://www.fda.gov/drugs/coronavirus-covid-19-drugs/coronavirus-treatment-acceleration-program-ctap [Accessed 26 May 2020].
2. European Medicines Agency (EMA) . Ema to support development of vaccines and treatments for novel coronavirus disease (COVID-19). Available: https://www.ema.europa.eu/en/news/ema-support-development-vaccines-treatments-novel-coronavirus-disease-covid-19 [Accessed 26 May 2020].
3. International Coalition of Medicines Regulatory Authorities (ICMRA) . Global regulators stress need for robust evidence on COVID-19 treatments. Available: http://www.icmra.info/drupal/en/news/9April2020 [Accessed 26 May 2020].
4. Anticancer Fund . ReDO project: Covid19_DB. Available: http://www.redo-project.org/covid19db/ [Accessed 23 Jun 2020].
5. World Health Organization (WHO) . International clinical trials registry platform (ICTP). Available: https://www.who.int/ictrp/en/ [Accessed 26 May 2020].